45
Participants
Start Date
March 8, 2022
Primary Completion Date
July 30, 2025
Study Completion Date
December 30, 2025
Hemodynamic measurements during reduction in Norepinephrine and fluid boli.
"1. Extended monitoring equipment will be connected to the patient. Clinical and biochemical parameters will be collected for a baseline before the next step. A Safety check will be performed to ensure correct patient data, correct equipment function and safety measures are meet. A passive leg raise test will be performed to predict fluid responsiveness, in case of a positive test, a fluid challenge will be administered.~2. A stepwise reduction of the NE infusion rate from baseline while monitoring stroke volume (SV) to elucidate changes in SV and potential preloadresponsiveness. The reduction will occur in steps of 3-5 minute until either discontinuation of the norepinephrine infusion, a 50% reduction in SV or MAP\<40.~3. While maintaining the NE infusion rate from the previous step 2, a fluid challenge will be administrated, until additional fluid does not increase SV\>10%.~4. As in step 2, a stepwise increase in NE infusion rate to the baseline infusion level or the baseline BP."
RECRUITING
Hvidovre Hospital, Hvidovre
University Hospital Bispebjerg and Frederiksberg
OTHER
Copenhagen University Hospital, Hvidovre
OTHER